(2R,4S)-2-{bis[2-chloro(2,2-2H2)ethyl]amino}-4-hydroxy-1,3,2λ5-oxazaphosphinan-2-one

• ChemBase编号: 170401
• 分子式: C7H15Cl2N2O3P
• 平均质量: 277.085361
• 单一同位素质量: 276.01973434
• SMILES: C1CO[P@](=O)(N[C@H]1O)N(CCCl)CCCl
• Canonical SMILES: ClCCN([P@]1(=O)OCC[C@@H](N1)O)CCCl
• InChI: InChI=1S/C7H15Cl2N2O3P/c8-2-4-11(5-3-9)15(13)10-7(12)1-6-14-15/h7,12H,1-6H2,(H,10,13)/t7-,15+/m0/s1
• InChIKey: RANONBLIHMVXAJ-NZFNHWASSA-N

名称和登记号

名称

• IUPAC标准名: (2R,4S)-2-{bis[2-chloro(2,2-^2H₂)ethyl]amino}-4-hydroxy-1,3,2λ^5-oxazaphosphinan-2-one
• IUPAC传统名: (2R,4S)-2-{bis[2-chloro(2,2-^2H₂)ethyl]amino}-4-hydroxy-1,3,2λ^5-oxazaphosphinan-2-one
• 别名: (2R,4S)-rel-2-[Bis(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorin-4-ol-d4 2-Oxide; (R,S)-4-Hydroxy Cyclophosphamide-d4, Preparation Kit

登记号

• PubChem SID: 164226311
• PubChem CID: 71748959

理论计算性质

• Acid pKa: 10.679547
• 质子受体: 3
• 质子供体: 2
• LogD (pH = 5.5): -0.057336807
• LogD (pH = 7.4): -0.057534993
• Log P: -0.057332873
• 摩尔折射率: 59.0944 cm^3
• 极化性: 24.068705 Å^3
• 极化表面积: 61.8 Å^2
• 可自由旋转的化学键: 5
• 里宾斯基五规则: true

分子性质

理化性质

• 外观: Colourless Solid

安全信息

• 保存条件: Hygroscopic, -86°C Freezer, Under Inert Atmosphere

详细说明

Toronto Research Chemicals - H926302

A labelled metabolite of Cyclophosphamide.This Kit consists of a vial of the oxidized precursor and a vial of the reducing agent. Simply add water to the reducing agent until it is completely dissolved and add this solution to the precursor. This solut

参考文献

• Peter, G., et al.: Cancer. Chemother. Pharmacol., 3, 181 (1979)
• Fenselau, C., et al.: Drug Metab. Dispos., 10, 636 (1979)
• Gamcsik, M., et al.: J. Med. Chem., 33, 1009 (1979)
• Habib, A., et al.: Biochem. Pharmacol., 50, 429 (1979)